Postvaccination prevalence of vaccine-Human Papillomavirus (vHPV) genotypes among the target population: A systematic review and meta-analysis.

Abstract

Human Papillomavirus (HPV) vaccines are safe and are highly effective in reducing the prevalence of HPV infections and subsequent HPV associated diseases in the target population. A systematic review and meta-analysis was carried out searching electronic databases for articles published between January 2007 and September 2020 reporting the prevalence estimates of vaccine HPV (vHPV) types in women who had received one or more doses of quadrivalent or bivalent vaccines. This systematic review was based on standard systematic review guidelines and the meta-analysis was performed by pooling the HPV vaccine type prevalence data with 95% confidence interval (CI) among 16,929 young women who had received the prophylactic HPV vaccines before the age of 27 years. The overall pooled prevalence of vHPV types was.0.04 (95% CI: 0.02, 0.05). The meta-analysis concludes that prophylactic HPV vaccination before the age of 27 years results in a decline of vHPV types in young women.

• Authors: Sasidharanpillai Sabeena, Nagaraja Ravishankar
• Journal: Journal of medical virology (J Med Virol) Vol. 93 Issue 8 Pg. 4659-4667 (08 2021) ISSN: 1096-9071 [Electronic] United States
• PMID: 33764530 (Publication Type: Journal Article, Meta-Analysis, Systematic Review)
• Copyright: © 2021 Wiley Periodicals LLC.

Chemical References

• Papillomavirus Vaccines

Topics

• Adult
• Female
• Genotype
• Global Health
• Humans
• Papillomavirus Infections (epidemiology, prevention & control, virology)
• Papillomavirus Vaccines (administration & dosage)
• Prevalence
• Uterine Cervical Neoplasms (epidemiology, virology)
• Vaccination (statistics & numerical data)